HER2 Support Group Forums - View Single Post - Clinical data for cabozantinib to be presented at ASCO annual meeting

News · 04-02-2012, 05:10 AM

Exelixis, Inc. announced today that its lead compound, cabozantinib, will be the subject of nine separate data presentations at the upcoming Annual Meeting of the American Society of Clinical Oncology.

More...

04-02-2012, 05:10 AM	#1
News Senior Member Join Date: Oct 2007 Posts: 18,963	Clinical data for cabozantinib to be presented at ASCO annual meeting Exelixis, Inc. announced today that its lead compound, cabozantinib, will be the subject of nine separate data presentations at the upcoming Annual Meeting of the American Society of Clinical Oncology. More...